Top MarketRank™ StocksTop MarketRank™Most-Downgraded StocksMost-DowngradedNYSE:EW Edwards Lifesciences (EW) Stock Price, News & Analysis $62.37 +2.67 (+4.47%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$60.28▼$63.8050-Day Range$59.70▼$93.7852-Week Range$58.93▼$96.12Volume14.08 million shsAverage Volume3.77 million shsMarket Capitalization$37.58 billionP/E Ratio26.88Dividend YieldN/APrice Target$83.45 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Edwards Lifesciences alerts: Email Address Edwards Lifesciences MarketRank™ Stock AnalysisAnalyst RatingHold2.41 Rating ScoreUpside/Downside31.6% Upside$82.10 Price TargetShort InterestHealthy1.30% of Float Sold ShortDividend StrengthN/ASustainability-0.95Upright™ Environmental ScoreNews Sentiment-0.18Based on 64 Articles This WeekInsider TradingSelling Shares$7 M Sold Last QuarterProj. Earnings Growth12.27%From $2.77 to $3.11 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.97 out of 5 starsMedical Sector10th out of 936 stocksSurgical Appliances & Supplies Industry1st out of 18 stocks 4.2 Analyst's Opinion Consensus RatingEdwards Lifesciences has received a consensus rating of Hold. The company's average rating score is 2.39, and is based on 10 buy ratings, 12 hold ratings, and 1 sell rating.Amount of Analyst CoverageEdwards Lifesciences has been the subject of 17 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Edwards Lifesciences' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.30% of the float of Edwards Lifesciences has been sold short.Short Interest Ratio / Days to CoverEdwards Lifesciences has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Edwards Lifesciences has recently decreased by 15.75%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldEdwards Lifesciences does not currently pay a dividend.Dividend GrowthEdwards Lifesciences does not have a long track record of dividend growth. Previous Next 4.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreEdwards Lifesciences has received a 54.55% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Catheters", "Mitral valve repair devices", and "Artificial heart valves" products. See details.Environmental SustainabilityThe Environmental Impact score for Edwards Lifesciences is -0.95. Previous Next 2.1 News and Social Media Coverage News SentimentEdwards Lifesciences has a news sentiment score of -0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 64 news articles for Edwards Lifesciences this week, compared to 12 articles on an average week.Search Interest23 people have searched for EW on MarketBeat in the last 30 days. This is an increase of 5% compared to the previous 30 days.MarketBeat Follows12 people have added Edwards Lifesciences to their MarketBeat watchlist in the last 30 days. This is an increase of 9% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Edwards Lifesciences insiders have sold 13,983.44% more of their company's stock than they have bought. Specifically, they have bought $49,729.00 in company stock and sold $7,003,553.00 in company stock.Percentage Held by InsidersOnly 1.29% of the stock of Edwards Lifesciences is held by insiders.Percentage Held by Institutions79.46% of the stock of Edwards Lifesciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Edwards Lifesciences' insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Edwards Lifesciences are expected to grow by 12.27% in the coming year, from $2.77 to $3.11 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Edwards Lifesciences is 26.88, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.35.Price to Earnings Ratio vs. SectorThe P/E ratio of Edwards Lifesciences is 26.88, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 156.32.Price to Earnings Growth RatioEdwards Lifesciences has a PEG Ratio of 3.18. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioEdwards Lifesciences has a P/B Ratio of 5.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Edwards Lifesciences' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.In answer to this issue, we have released a Special Report to the public. About Edwards Lifesciences Stock (NYSE:EW)Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.Read More EW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EW Stock News HeadlinesJuly 11, 2024 | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) VP Sells $466,450.00 in StockJuly 26 at 8:48 PM | markets.businessinsider.comBarclays Keeps Their Buy Rating on Edwards Lifesciences (EW)July 26, 2024 | DTI (Ad)How a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…July 26 at 8:48 PM | seekingalpha.comEdwards Lifesciences Q2: Buy The Dip Amid Guidance CutJuly 26 at 8:48 PM | benzinga.comMarket Whales and Their Recent Bets on Edwards Lifesciences OptionsJuly 26 at 8:48 PM | msn.comB of A Securities Downgrades Edwards Lifesciences (EW)July 26 at 8:14 AM | americanbankingnews.comEdwards Lifesciences (NYSE:EW) Lowered to Hold at Baird R WJuly 26 at 7:28 AM | americanbankingnews.comJPMorgan Chase & Co. Downgrades Edwards Lifesciences (NYSE:EW) to NeutralJuly 26, 2024 | DTI (Ad)How a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…July 26 at 7:28 AM | americanbankingnews.comEdwards Lifesciences (NYSE:EW) Downgraded to "Neutral" at Bank of AmericaJuly 25 at 10:05 PM | seekingalpha.comEdwards Lifesciences Corporation (EW) Q2 2024 Earnings Call TranscriptJuly 25 at 10:05 PM | msn.comEdwards Lifesciences (NYSE:EW) Plunges 31% after J.P. Morgan and Truist DowngradesJuly 25 at 5:59 PM | investopedia.comS&P 500 Gains and Losses Today: Edwards Lifesciences Sinks on Outlook for Key ProductJuly 25 at 5:04 PM | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Edwards Lifesciences (EW)July 25 at 5:04 PM | benzinga.comThese Analysts Slash Their Forecasts On Edwards Lifesciences Following Q2 ResultsJuly 25 at 5:04 PM | reuters.comEdwards Lifesciences misses Q2 revenue estimates on weak demand for heart devicesJuly 25 at 5:04 PM | msn.comEdwards Lifesciences Stock Plummeted Today. Here's WhyJuly 25 at 4:56 PM | investopedia.comEdwards Lifesciences Stock Plummeted Today. Here's WhySee More Headlines Receive EW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Edwards Lifesciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/24/2024Today7/26/2024Next Earnings (Estimated)10/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryHealth Care Equipment Current SymbolNYSE:EW CUSIP28176E10 CIK1099800 Webwww.edwards.com Phone(949) 250-2500Fax949-250-2525Employees19,800Year Founded1958Price Target and Rating Average Stock Price Target$82.10 High Stock Price Target$106.00 Low Stock Price Target$57.00 Potential Upside/Downside+33.8%Consensus RatingHold Rating Score (0-4)2.41 Research Coverage23 Analysts Profitability EPS (Most Recent Fiscal Year)$2.32 Trailing P/E Ratio26.88 Forward P/E Ratio22.52 P/E Growth3.18Net Income$1.40 billion Net Margins24.55% Pretax Margin26.19% Return on Equity22.86% Return on Assets16.57% Debt Debt-to-Equity Ratio0.08 Current Ratio3.75 Quick Ratio2.67 Sales & Book Value Annual Sales$6.00 billion Price / Sales6.26 Cash Flow$1.98 per share Price / Cash Flow31.47 Book Value$11.08 per share Price / Book5.63Miscellaneous Outstanding Shares602,600,000Free Float594,826,000Market Cap$37.58 billion OptionableOptionable Beta1.11 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Bernard J. Zovighian (Age 56)CEO & Director Comp: $2.27MMr. Scott B. Ullem (Age 57)Corporate VP & CFO Comp: $1.35MMr. Donald E. Bobo Jr. (Age 62)Corporate Vice President of Strategy & Corporate Development Comp: $1.27MMr. Larry L. Wood (Age 58)Corporate VP and Group President of TAVR & Surgical Structural Heart Comp: $1.49MDr. Todd J. Brinton FACCM.D., Corporate VP of Advanced Technology & Chief Scientific OfficerMark WilterdingVice President of Investor RelationsMr. Arnold A. Pinkston (Age 65)Corporate VP & General Counsel Mr. Dirksen J. LehmanCorporate Vice President of Public AffairsMs. Christine Z. McCauley (Age 59)Corporate Vice President of Human Resources Mr. Gary I. Sorsher (Age 59)Senior Vice President of Quality & Regulatory Compliance More ExecutivesKey CompetitorsAbbott LaboratoriesNYSE:ABTIntuitive SurgicalNASDAQ:ISRGStrykerNYSE:SYKBoston ScientificNYSE:BSXMedtronicNYSE:MDTView All CompetitorsInsiders & InstitutionsAspen Investment Management IncBought 200 shares on 7/26/2024Ownership: 0.002%Checchi Capital Advisers LLCBought 212 shares on 7/26/2024Ownership: 0.001%Atomi Financial Group Inc.Bought 274 shares on 7/26/2024Ownership: 0.001%Granite Harbor Advisors Inc.Bought 185 shares on 7/26/2024Ownership: 0.001%Catalyst Financial Partners LLCBought 232 shares on 7/26/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions Should I Buy Edwards Lifesciences Stock? EW Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in Edwards Lifesciences Co.: Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in various regions, indicating a diverse market presence. Recent developments in transcatheter heart valve replacement products offer minimally invasive options for aortic heart conditions, showcasing innovation in the healthcare sector. Strong performance in the critical care monitoring segment highlights the company's ability to adapt to changing healthcare needs and capitalize on emerging trends. Positive market reception and demand for Edwards Lifesciences Co.'s products indicate a favorable outlook for revenue growth and market expansion. Current stock price of Edwards Lifesciences Co. reflects a stable and potentially lucrative investment opportunity for investors seeking growth in the healthcare industry. Cons Investors should be bearish about investing in Edwards Lifesciences Co. for these reasons: East West Petroleum Corp., a different company with a similar symbol, engages in oil and gas exploration and production, potentially causing confusion for investors looking specifically at Edwards Lifesciences Co. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, July 22, 2024. Please send any questions or comments about these Edwards Lifesciences pros and cons to contact@marketbeat.com. EW Stock Analysis - Frequently Asked Questions How have EW shares performed this year? Edwards Lifesciences' stock was trading at $76.25 on January 1st, 2024. Since then, EW shares have decreased by 18.2% and is now trading at $62.37. View the best growth stocks for 2024 here. How were Edwards Lifesciences' earnings last quarter? Edwards Lifesciences Co. (NYSE:EW) announced its quarterly earnings results on Wednesday, July, 24th. The medical research company reported $0.70 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.69 by $0.01. The firm's revenue was up 6.7% on a year-over-year basis. Read the conference call transcript. When did Edwards Lifesciences' stock split? Edwards Lifesciences shares split on Friday, May 29th 2020. The 3-1 split was announced on Thursday, May 7th 2020. The newly created shares were issued to shareholders after the closing bell on Monday, May 18th 2020. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. What is Michael A. Mussallem's approval rating as Edwards Lifesciences' CEO? 389 employees have rated Edwards Lifesciences Chief Executive Officer Michael A. Mussallem on Glassdoor.com. Michael A. Mussallem has an approval rating of 90% among the company's employees. Does Edwards Lifesciences have any subsidiaries? The following companies are subsidiaries of Edwards Lifesciences: CAS Medical Systems, Harpoon Medical, Valtech Cardio, CardiAQ Valve Technologies, BMEYE, Embrella Cardiovascular, Myocor, and more. Who are Edwards Lifesciences' major shareholders? Top institutional shareholders of Edwards Lifesciences include Bank of New York Mellon Corp (3.28%), AustralianSuper Pty Ltd (0.46%), Raymond James & Associates (0.30%) and Railway Pension Investments Ltd (0.23%). Insiders that own company stock include Larry L Wood, Jean-Luc M Lemercier, Bernard J Zovighian, Kieran Gallahue, Donald E Bobo Jr, Catherine M Szyman, Scott B Ullem, Heisz Leslie Stone, Martha H Marsh, Daniel J Lippis, Daveen Chopra, Robert WA Sellers, Michael A Mussallem, Nicholas J Valeriani and Huimin Wang. View institutional ownership trends. How do I buy shares of Edwards Lifesciences? Shares of EW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Edwards Lifesciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Edwards Lifesciences investors own include NVIDIA (NVDA), Alibaba Group (BABA), Home Depot (HD), Salesforce (CRM), Walt Disney (DIS), Visa (V) and Johnson & Johnson (JNJ). This page (NYSE:EW) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EW Stock Alerts